BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Pharm Country

  The Medicines Company to Participate in the Jefferies and Co. 2011 Global Healthcare Conference

  June 1, 2011

   · 

  1 min read
• W. L. Gore & Associates, Inc. Hybrid Vascular Graft Commercially Available in the United States

  June 1, 2011

   · 

  1 min read
• Shield Therapeutics Raises EUR8.2 Million From Inventages Venture Capital Via Series A Institutional Round

  June 1, 2011

   · 

  3 min read
• Genetown

  ConforMIS Announces Completion of the First iTotal(R) CR Knee Resurfacing System Surgeries

  June 1, 2011

   · 

  1 min read
• Pharm Country

  Ventrus Biosciences, Inc. Receives Notice of Allowance for U.S. Patent for VEN 307

  June 1, 2011

   · 

  1 min read
• Deals

  Laboratory Corporation of America Holdings (LabCorp) Enters into Definitive Agreement to Acquire Clearstone Central Laboratories

  June 1, 2011

   · 

  1 min read
• Biotech Bay

  Align Technology, Inc. Announces Commercial Availability of Invisalign in China

  June 1, 2011

   · 

  1 min read
• BioCapital

  Applied Visual Sciences Update of Ongoing Business Activities

  June 1, 2011

   · 

  9 min read
• Drug Development

  CrystalGenomics Initiates CG100649 Phase 2b Study in Patients with Osteoarthritis

  June 1, 2011

   · 

  3 min read
• Drug Development

  Eisai Inc.: Phase II Study Results Showed Eisai’s Lenvatinib (E7080) Demonstrated an Objective Response Rate of 59% in Radioiodine (RAI)-Refractory Differentiated Thyroid Cancer

  June 1, 2011

   · 

  1 min read